Accenture Stock Faces Challenges Amid Mixed Quarterly Results
Accenture plc (ACN), with a market cap of $192.8 billion, provides a range of services including strategy, consulting, technology, and operations both in North America and globally. Established in 1951 and headquartered in Dublin, Ireland, the firm specializes in systems integration, application management, security, intelligent platforms, infrastructure, software engineering, data, and AI.
Recent Stock Performance
Over the past year, shares of Accenture have underperformed the broader market, experiencing a 5.1% increase within 52 weeks while dropping 8.4% year-to-date. In contrast, the S&P 500 Index ($SPX) has returned 11.9% during the same period and has shown a slight decline in 2025.
Focusing on the Technology Select Sector SPDR Fund (XLK), ACN has also lagged behind, with the fund gaining 10.8% over the past year and experiencing a 2.1% decrease this year.
Mixed Q2 Results Impact Stock Price
After releasing mixed Q2 results on March 20, Accenture’s stock price fell by 7.3%. The company reported a 5.4% year-over-year revenue growth to $16.7 billion, slightly surpassing analyst expectations. However, its earnings per share (EPS) increased nearly 7% to $2.82, which was just below analyst forecasts.
Outlook and Analyst Ratings
For the fiscal year ending in August, analysts forecast a 6.1% increase in ACN’s EPS to $12.68. In the past four quarters, the company has exceeded consensus estimates in two instances while missing expectations in the other two.
The consensus rating among the 24 analysts covering Accenture is a “Moderate Buy,” based on 16 “Strong Buy” ratings, one “Moderate Buy,” and seven “Holds.” This outlook is slightly more optimistic than three months ago when only 15 analysts issued a “Strong Buy.”
On April 16, Piper Sandler Companies (PIPR) analyst Arvind Ramnani reiterated a “Buy” rating on Accenture while adjusting the target price from $364 to $355. The mean price target for ACN stands at $361.04, reflecting a 12.1% premium from current market prices. Notably, the highest target of $415 indicates significant upside potential of 28.8% from present levels.
On the date of publication, Kritika Sarmah did not hold positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For further details, please review the Barchart Disclosure Policy here.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
